Showing results (121-130 of 498) with videos related to

Sort By:
Pageof 50
Annals of Hematology|June 7, 2019
Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practiceEmilia Scalzulli, Matteo Molica, Danilo Alunni Fegatelli, et al.
Oncotarget|February 28, 2018
Prognostic factors associated with a stable MR4.5 achievement in chronic myeloid leukemia patients treated with imatinibMassimo Breccia, Matteo Molica, Gioia Colafigli, et al.
British Journal of Haematology|August 16, 2005
The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experienceMassimo Gentile, Francesca Romana Mauro, Elisabetta Calabrese, et al.
Mabs|August 13, 2013
Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamicsJosée Golay, Gianpietro Semenzato, Alessandro Rambaldi, et al.
Leukemia Research|February 29, 2008
Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levelsRoberta Riccioni, Mara Senese, Daniela Diverio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2013
Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapyFederica Moschella, Giovanni Fernando Torelli, Mara Valentini, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 10, 2016
Life-Threatening Autoimmune Hemolytic Anemia and Idhiopatic Thrombocytopenic Purpura. Successful Selective Splenic Artery EmbolizationMatteo Molica, Fulvio Massaro, Giorgia Annechini, et al.
BMC Infectious Diseases|March 12, 2017
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremiasAlessandra Micozzi, Giuseppe Gentile, Clara Minotti, et al.
Leukemia Research|December 29, 2009
Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitorsSimona Tavolaro, Sabina Chiaretti, Monica Messina, et al.
Blood|August 16, 2015
Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemiasMaria Rosaria Ricciardi, Simone Mirabilii, Matteo Allegretti, et al.
Pageof 50